Reuters Pharma USA 2024 – Jeffrey Meckler
pharmaphorum
APRIL 10, 2024
Stay updated on the latest insights from Jeffrey Meckler, CEO of Indaptus Therapeutics, in a recent exclusive interview at Reuters Pharma USA 2024. Learn more about the industry trends and advancements he discusses in this video interview.
Let's personalize your content